|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R89.6 |
Abnormal cytological findings in specimens from other organs, systems and tissues
|
R896 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 30.98%
|
38.36%
|
13.33%
|
6.12%
|
3.80%
|
1.93%
|
1.10%
|
0.87%
|
0.55%
|
0.61%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R89.6*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
372
|
568
|
|
88173
|
CYTOPATH EVAL FNA REPORT |
278
|
337
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
226
|
248
|
|
10005
|
FNA BX W/US GDN 1ST LES |
155
|
155
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
141
|
142
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
116
|
453
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
112
|
148
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
110
|
110
|
|
J3010
|
FENTANYL CITRATE INJECTION |
103
|
138
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
86
|
86
|
|
88185
|
FLOWCYTOMETRY/TC ADD-ON |
84
|
893
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
82
|
2,333
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
73
|
171
|
|
J2405
|
ONDANSETRON HCL INJECTION |
69
|
272
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
61
|
4,405
|
|
88172
|
CYTP DX EVAL FNA 1ST EA SITE |
61
|
73
|
|
85610
|
PROTHROMBIN TIME |
55
|
55
|
|
52000
|
CYSTOURETHROSCOPY |
54
|
54
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
51
|
300
|
|
88184
|
FLOWCYTOMETRY/ TC 1 MARKER |
47
|
50
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R89.6 related to the following DRG Codes:
947-948
|
